Investing.com - Surgalign Holdings (NASDAQ: SRGA) reported first quarter EPS of $-1.2200, $0.60 better than the analyst estimate of $-1.8200. Revenue for the quarter came in at $20.6M versus the consensus estimate of $20.65M.
Surgalign Holdings's stock price closed at $1.6600. It is down -16.5800% in the last 3 months and down -81.8200% in the last 12 months.
Surgalign Holdings saw 2 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See Surgalign Holdings's stock price’s past reactions to earnings here.
According to InvestingPro, Surgalign Holdings's Financial Health score is "weak performance".
Check out Surgalign Holdings's recent earnings performance, and Surgalign Holdings's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar
SRGAQ: is this perennial leader facing new challenges?
With valuations skyrocketing in 2024, many investors are uneasy putting more money into stocks. Sure, there are always opportunities in the stock market – but finding them feels more difficult now than a year ago. Unsure where to invest next? One of the best ways to discover new high-potential opportunities is to look at the top performing portfolios this year. ProPicks AI offers 6 model portfolios from Investing.com which identify the best stocks for investors to buy right now. For example, ProPicks AI found 9 overlooked stocks that jumped over 25% this year alone. The new stocks that made the monthly cut could yield enormous returns in the coming years. Is SRGAQ one of them?
Unlock ProPicks AI to find out